Shernan Holtan, MD, and Rahul Banerjee, MD, FACP, discussed various trials of significance shared as posters and presentations at the 2025 Tandem Meeting.
Shernan Holtan, MD
Advertisement
Articles by Shernan Holtan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Intismeran Plus Pembrolizumab Reduces Recurrence Risk in Resected Melanoma
2
Perioperative Pembrolizumab Plus Chemo Does Not Significantly Improve EFS in MIBC
3
Top Poster Takeaways for Prostate Cancer From 2026 ESMO Congress
4
Adjuvant Ribociclib Improves OS at 6 Years in HR+/HER2- Early Breast Cancer
5